Company now in drivers seat with buyout negotiations, they don't need cash, they have a great billion dollar drug and competitor who's drug is questionable to get full approval without black box warning. Stock will run into 20's. Debt offering can be paid off early without penalty in case of buyout.
more testing will likely be required before FDA decided on chronic market. RLYP will fly on short squeeze and B.O. buyers will line up to grab RLYP. 50+
watch for big rebound back up!
coming up on a lot of good news on script numbers and likely FDA either putting a black box warning on competitors product or requiring more testing or outright rejection.
a deal will definitely be done only question is at what price.
when there is this much movement on heavy volume there is something in the works
break of 20 coming
look for buyout at RLYP soon. Multiple parties looking at it as its way undervalued.
This is one of the best launched in this area in years!
RLYP will fly!
The financing deal was just cosmetic to show they are covered if need be to go it alone and put a death nail into the shorts thesis they were going to dilute stock with low price issuance. It also gives them credibility to those that made low ball bids for the company thinking they were desperate for cash. They are in the seat driving this now, so when companies come knocking they can say get lost if your not willing to pay up.
to compete with CIC and Lizzie which are in hands of bigger pharma, they need to sell out to a major pharma company and big pharma needs SGYP too. Deal is forthcoming!
possible buyout from multiple parties that have approached them and this opens up at 38
could happen any time and shorts won't have opportunity to cover